N Engl J Med
. 2021 Jun 23.
doi: 10.1056/NEJMsr2105280. Online ahead of print.
SARS-CoV-2 Variants and Vaccines
Philip R Krause 1 , Thomas R Fleming 1 , Ira M Longini 1 , Richard Peto 1 , Sylvie Briand 1 , David L Heymann 1 , Valerie Beral 1 , Matthew D Snape 1 , Helen Rees 1 , Alba-Maria Ropero 1 , Ran D Balicer 1 , Jakob P Cramer 1 , César Muñoz-Fontela 1 , Marion Gruber 1 , Rogerio Gaspar 1 , Jerome A Singh 1 , Kanta Subbarao 1 , Maria D Van Kerkhove 1 , Soumya Swaminathan 1 , Michael J Ryan 1 , Ana-Maria Henao-Restrepo 1
Affiliations
- PMID: 34161052
- DOI: 10.1056/NEJMsr2105280
Abstract
Viral variants of concern may emerge with dangerous resistance to the immunity generated by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some variants of concern have increased transmissibility or virulence, the importance of efficient public health measures and vaccination programs will increase. The global response must be both timely and science based.